—A recent analysis showed that health concerns, rather than costs, influenced treatment strategies in commercially insured men with prostate cancer. Among men with newly diagnosed prostate cancer, ...

A 2-step decision analytic model consisting of a decision tree-informed Markov structure was used to estimate lifetime outcomes in older patients with prostate cancer. The P-score reclassifies a ...

2024 OCT 23 (NewsRx) -- By a News Reporter-Staff News Editor at Insurance Daily News-- Current study results on Oncology - Prostate Cancer have been published. According to news reporting originating ...

Prostate-specific antigen (PSA) screening aims to identify men who may harbor potentially lethal prostate cancer, and those with high PSA results often require more extensive (and expensive) ...

These substantial increases highlight the growing financial burden on patients undergoing necessary diagnostic testing following an abnormal PSA test. Out-of-pocket costs (OOPCs) for diagnostic ...

A new model that compares costs and outcomes of drugs used in the treatment of castrate-resistant prostate cancer has concluded that generic docetaxel and abiraterone (Zytiga) offer better value than ...

A research team from the Department of Surgery and the Department of Medicine, School of Clinical Medicine, LKS Faculty of Medicine, the University of Hong Kong (HKUMed), has demonstrated that ...

Out-of-pocket costs for tests used to diagnose prostate cancer have increased in recent years, according to research published in Cancer. Researchers found that out-of-pocket costs for prostate biopsy ...

A research team from the Department of Surgery and the Department of Medicine, School of Clinical Medicine, LKS Faculty of Medicine, the University of Hong Kong (HKUMed), has demonstrated that ...

HUNTSVILLE, Ala. (WHNT) — A new law is taking effect in Alabama next year that will make prostate cancer screenings more affordable. The law will require insurance companies to fully cover prostate ...

If you or a loved one has prostate cancer, you may be interested in learning about medicines used to treat it. One option is a medicine called Erleada (apalutamide). The FDA approved Erleada in 2018.